Global Antisense Oligonucleotides (ASOs) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 99

Published Date: 21 May 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).

According to our (Global Info Research) latest study, the global Antisense Oligonucleotides (ASOs) Drugs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Antisense Oligonucleotides (ASOs) Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Antisense Oligonucleotides (ASOs) Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Antisense Oligonucleotides (ASOs) Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Antisense Oligonucleotides (ASOs) Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Antisense Oligonucleotides (ASOs) Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antisense Oligonucleotides (ASOs) Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antisense Oligonucleotides (ASOs) Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonis Pharmaceuticals, Novartis, Sanofi, GSK, Sarepta, Kastle, Biogen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Antisense Oligonucleotides (ASOs) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Cleave and Degrade
    Splice

Market segment by Application
    Hospital
    Clinic

Major players covered
    Lonis Pharmaceuticals
    Novartis
    Sanofi
    GSK
    Sarepta
    Kastle
    Biogen

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antisense Oligonucleotides (ASOs) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antisense Oligonucleotides (ASOs) Drugs, with price, sales quantity, revenue, and global market share of Antisense Oligonucleotides (ASOs) Drugs from 2019 to 2024.
Chapter 3, the Antisense Oligonucleotides (ASOs) Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antisense Oligonucleotides (ASOs) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Antisense Oligonucleotides (ASOs) Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antisense Oligonucleotides (ASOs) Drugs.
Chapter 14 and 15, to describe Antisense Oligonucleotides (ASOs) Drugs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Cleave and Degrade
        1.3.3 Splice
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
    1.5 Global Antisense Oligonucleotides (ASOs) Drugs Market Size & Forecast
        1.5.1 Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity (2019-2030)
        1.5.3 Global Antisense Oligonucleotides (ASOs) Drugs Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Lonis Pharmaceuticals
        2.1.1 Lonis Pharmaceuticals Details
        2.1.2 Lonis Pharmaceuticals Major Business
        2.1.3 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product and Services
        2.1.4 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Lonis Pharmaceuticals Recent Developments/Updates
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Antisense Oligonucleotides (ASOs) Drugs Product and Services
        2.2.4 Novartis Antisense Oligonucleotides (ASOs) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Novartis Recent Developments/Updates
    2.3 Sanofi
        2.3.1 Sanofi Details
        2.3.2 Sanofi Major Business
        2.3.3 Sanofi Antisense Oligonucleotides (ASOs) Drugs Product and Services
        2.3.4 Sanofi Antisense Oligonucleotides (ASOs) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Sanofi Recent Developments/Updates
    2.4 GSK
        2.4.1 GSK Details
        2.4.2 GSK Major Business
        2.4.3 GSK Antisense Oligonucleotides (ASOs) Drugs Product and Services
        2.4.4 GSK Antisense Oligonucleotides (ASOs) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 GSK Recent Developments/Updates
    2.5 Sarepta
        2.5.1 Sarepta Details
        2.5.2 Sarepta Major Business
        2.5.3 Sarepta Antisense Oligonucleotides (ASOs) Drugs Product and Services
        2.5.4 Sarepta Antisense Oligonucleotides (ASOs) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Sarepta Recent Developments/Updates
    2.6 Kastle
        2.6.1 Kastle Details
        2.6.2 Kastle Major Business
        2.6.3 Kastle Antisense Oligonucleotides (ASOs) Drugs Product and Services
        2.6.4 Kastle Antisense Oligonucleotides (ASOs) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Kastle Recent Developments/Updates
    2.7 Biogen
        2.7.1 Biogen Details
        2.7.2 Biogen Major Business
        2.7.3 Biogen Antisense Oligonucleotides (ASOs) Drugs Product and Services
        2.7.4 Biogen Antisense Oligonucleotides (ASOs) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Biogen Recent Developments/Updates

3 Competitive Environment: Antisense Oligonucleotides (ASOs) Drugs by Manufacturer
    3.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Manufacturer (2019-2024)
    3.3 Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Antisense Oligonucleotides (ASOs) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Antisense Oligonucleotides (ASOs) Drugs Manufacturer Market Share in 2023
        3.4.3 Top 6 Antisense Oligonucleotides (ASOs) Drugs Manufacturer Market Share in 2023
    3.5 Antisense Oligonucleotides (ASOs) Drugs Market: Overall Company Footprint Analysis
        3.5.1 Antisense Oligonucleotides (ASOs) Drugs Market: Region Footprint
        3.5.2 Antisense Oligonucleotides (ASOs) Drugs Market: Company Product Type Footprint
        3.5.3 Antisense Oligonucleotides (ASOs) Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Antisense Oligonucleotides (ASOs) Drugs Market Size by Region
        4.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Region (2019-2030)
        4.1.2 Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Region (2019-2030)
        4.1.3 Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Region (2019-2030)
    4.2 North America Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030)
    4.3 Europe Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030)
    4.4 Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030)
    4.5 South America Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030)
    4.6 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2030)
    5.2 Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Type (2019-2030)
    5.3 Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2030)
    6.2 Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Application (2019-2030)
    6.3 Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Application (2019-2030)

7 North America
    7.1 North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2030)
    7.2 North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2030)
    7.3 North America Antisense Oligonucleotides (ASOs) Drugs Market Size by Country
        7.3.1 North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2019-2030)
        7.3.2 North America Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2030)
    8.2 Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2030)
    8.3 Europe Antisense Oligonucleotides (ASOs) Drugs Market Size by Country
        8.3.1 Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2019-2030)
        8.3.2 Europe Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Market Size by Region
        9.3.1 Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2030)
    10.2 South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2030)
    10.3 South America Antisense Oligonucleotides (ASOs) Drugs Market Size by Country
        10.3.1 South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2019-2030)
        10.3.2 South America Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Market Size by Country
        11.3.1 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Antisense Oligonucleotides (ASOs) Drugs Market Drivers
    12.2 Antisense Oligonucleotides (ASOs) Drugs Market Restraints
    12.3 Antisense Oligonucleotides (ASOs) Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Antisense Oligonucleotides (ASOs) Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Antisense Oligonucleotides (ASOs) Drugs
    13.3 Antisense Oligonucleotides (ASOs) Drugs Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Antisense Oligonucleotides (ASOs) Drugs Typical Distributors
    14.3 Antisense Oligonucleotides (ASOs) Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Lonis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 4. Lonis Pharmaceuticals Major Business
 Table 5. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 6. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Lonis Pharmaceuticals Recent Developments/Updates
 Table 8. Novartis Basic Information, Manufacturing Base and Competitors
 Table 9. Novartis Major Business
 Table 10. Novartis Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 11. Novartis Antisense Oligonucleotides (ASOs) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Novartis Recent Developments/Updates
 Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 14. Sanofi Major Business
 Table 15. Sanofi Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 16. Sanofi Antisense Oligonucleotides (ASOs) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Sanofi Recent Developments/Updates
 Table 18. GSK Basic Information, Manufacturing Base and Competitors
 Table 19. GSK Major Business
 Table 20. GSK Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 21. GSK Antisense Oligonucleotides (ASOs) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. GSK Recent Developments/Updates
 Table 23. Sarepta Basic Information, Manufacturing Base and Competitors
 Table 24. Sarepta Major Business
 Table 25. Sarepta Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 26. Sarepta Antisense Oligonucleotides (ASOs) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Sarepta Recent Developments/Updates
 Table 28. Kastle Basic Information, Manufacturing Base and Competitors
 Table 29. Kastle Major Business
 Table 30. Kastle Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 31. Kastle Antisense Oligonucleotides (ASOs) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Kastle Recent Developments/Updates
 Table 33. Biogen Basic Information, Manufacturing Base and Competitors
 Table 34. Biogen Major Business
 Table 35. Biogen Antisense Oligonucleotides (ASOs) Drugs Product and Services
 Table 36. Biogen Antisense Oligonucleotides (ASOs) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Biogen Recent Developments/Updates
 Table 38. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
 Table 39. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 40. Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 41. Market Position of Manufacturers in Antisense Oligonucleotides (ASOs) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 42. Head Office and Antisense Oligonucleotides (ASOs) Drugs Production Site of Key Manufacturer
 Table 43. Antisense Oligonucleotides (ASOs) Drugs Market: Company Product Type Footprint
 Table 44. Antisense Oligonucleotides (ASOs) Drugs Market: Company Product Application Footprint
 Table 45. Antisense Oligonucleotides (ASOs) Drugs New Market Entrants and Barriers to Market Entry
 Table 46. Antisense Oligonucleotides (ASOs) Drugs Mergers, Acquisition, Agreements, and Collaborations
 Table 47. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 48. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Region (2019-2024) & (K Units)
 Table 49. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Region (2025-2030) & (K Units)
 Table 50. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Region (2019-2024) & (USD Million)
 Table 51. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Region (2025-2030) & (USD Million)
 Table 52. Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Region (2019-2024) & (US$/Unit)
 Table 53. Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Region (2025-2030) & (US$/Unit)
 Table 54. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 55. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 56. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Type (2019-2024) & (USD Million)
 Table 57. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Type (2025-2030) & (USD Million)
 Table 58. Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Type (2019-2024) & (US$/Unit)
 Table 59. Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Type (2025-2030) & (US$/Unit)
 Table 60. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 61. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 62. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Application (2019-2024) & (USD Million)
 Table 63. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Application (2025-2030) & (USD Million)
 Table 64. Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Application (2019-2024) & (US$/Unit)
 Table 65. Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Application (2025-2030) & (US$/Unit)
 Table 66. North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 67. North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 68. North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 69. North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 70. North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2019-2024) & (K Units)
 Table 71. North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2025-2030) & (K Units)
 Table 72. North America Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 73. North America Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 74. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 75. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 76. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 77. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 78. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2019-2024) & (K Units)
 Table 79. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2025-2030) & (K Units)
 Table 80. Europe Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 81. Europe Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 82. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 83. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 84. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 85. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 86. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Region (2019-2024) & (K Units)
 Table 87. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Region (2025-2030) & (K Units)
 Table 88. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Region (2019-2024) & (USD Million)
 Table 89. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Region (2025-2030) & (USD Million)
 Table 90. South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 91. South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 92. South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 93. South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 94. South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2019-2024) & (K Units)
 Table 95. South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2025-2030) & (K Units)
 Table 96. South America Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 97. South America Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 98. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 99. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 100. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 101. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 102. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2019-2024) & (K Units)
 Table 103. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity by Country (2025-2030) & (K Units)
 Table 104. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 105. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 106. Antisense Oligonucleotides (ASOs) Drugs Raw Material
 Table 107. Key Manufacturers of Antisense Oligonucleotides (ASOs) Drugs Raw Materials
 Table 108. Antisense Oligonucleotides (ASOs) Drugs Typical Distributors
 Table 109. Antisense Oligonucleotides (ASOs) Drugs Typical Customers


List of Figures
 Figure 1. Antisense Oligonucleotides (ASOs) Drugs Picture
 Figure 2. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Type in 2023
 Figure 4. Cleave and Degrade Examples
 Figure 5. Splice Examples
 Figure 6. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Application in 2023
 Figure 8. Hospital Examples
 Figure 9. Clinic Examples
 Figure 10. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 11. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 12. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity (2019-2030) & (K Units)
 Figure 13. Global Antisense Oligonucleotides (ASOs) Drugs Price (2019-2030) & (US$/Unit)
 Figure 14. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Manufacturer in 2023
 Figure 15. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Manufacturer in 2023
 Figure 16. Producer Shipments of Antisense Oligonucleotides (ASOs) Drugs by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 17. Top 3 Antisense Oligonucleotides (ASOs) Drugs Manufacturer (Revenue) Market Share in 2023
 Figure 18. Top 6 Antisense Oligonucleotides (ASOs) Drugs Manufacturer (Revenue) Market Share in 2023
 Figure 19. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Region (2019-2030)
 Figure 20. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value Market Share by Region (2019-2030)
 Figure 21. North America Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 22. Europe Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 23. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 24. South America Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 25. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 26. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 27. Global Antisense Oligonucleotides (ASOs) Drugs Consumption Value Market Share by Type (2019-2030)
 Figure 28. Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Type (2019-2030) & (US$/Unit)
 Figure 29. Global Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 30. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Application (2019-2030)
 Figure 31. Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Application (2019-2030) & (US$/Unit)
 Figure 32. North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 33. North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 34. North America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Country (2019-2030)
 Figure 35. North America Antisense Oligonucleotides (ASOs) Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 36. United States Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 37. Canada Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 38. Mexico Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 39. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 40. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 41. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Country (2019-2030)
 Figure 42. Europe Antisense Oligonucleotides (ASOs) Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 43. Germany Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 44. France Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 45. United Kingdom Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 46. Russia Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 47. Italy Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 48. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 49. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 50. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Region (2019-2030)
 Figure 51. Asia-Pacific Antisense Oligonucleotides (ASOs) Drugs Consumption Value Market Share by Region (2019-2030)
 Figure 52. China Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 53. Japan Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 54. South Korea Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 55. India Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 56. Southeast Asia Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 57. Australia Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 58. South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 59. South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 60. South America Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Country (2019-2030)
 Figure 61. South America Antisense Oligonucleotides (ASOs) Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 62. Brazil Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 63. Argentina Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 64. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 65. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 66. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Quantity Market Share by Country (2019-2030)
 Figure 67. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 68. Turkey Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 69. Egypt Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 70. Saudi Arabia Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 71. South Africa Antisense Oligonucleotides (ASOs) Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 72. Antisense Oligonucleotides (ASOs) Drugs Market Drivers
 Figure 73. Antisense Oligonucleotides (ASOs) Drugs Market Restraints
 Figure 74. Antisense Oligonucleotides (ASOs) Drugs Market Trends
 Figure 75. Porters Five Forces Analysis
 Figure 76. Manufacturing Cost Structure Analysis of Antisense Oligonucleotides (ASOs) Drugs in 2023
 Figure 77. Manufacturing Process Analysis of Antisense Oligonucleotides (ASOs) Drugs
 Figure 78. Antisense Oligonucleotides (ASOs) Drugs Industrial Chain
 Figure 79. Sales Channel: Direct to End-User vs Distributors
 Figure 80. Direct Channel Pros & Cons
 Figure 81. Indirect Channel Pros & Cons
 Figure 82. Methodology
 Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lonis Pharmaceuticals
Novartis
Sanofi
GSK
Sarepta
Kastle
Biogen

Related Reports

Global Antisense Oligonucleotides (ASOs) Drugs Supply, Demand and Key Producers, 2024-2030

Global Antisense Oligonucleotides (ASOs) Drugs Supply, Demand and Key Producers, 2024-2030

date 21 May 2024

date Pharma & Healthcare

Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).

Product Tags

Antisense Oligonucleotides (ASOs) Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>